Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
DCIS
(section)
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Other treatment considerations == * Margins ** Controversial ** >2mm is often considered adequate to declare negative margin - does not significantly increase recurrence rate compared to bigger margins ** <2mm should be considered for re-excision, although >1mm is acceptable in the UK * SLNB ** Not typically performed with DCIS unless doing a mastectomy ** Indications *** Microinvasion on core biopsy *** Otherwise concerning for invasive disease *** Mastectomy for DCIS (since won't be able to do it later if it's upstaged to invasive on pathology specimen) *** High-grade, large (>5cm) or palpable DCIS (since there may be a subsequent upstaging based on pathological specimen, which happens about 15% of the time in this cohort) * Hormone therapy ** If DCIS is ER/PR positive, can give adjuvant hormone therapy for 5 years (either anastrazole or tamoxifen are ok) ** Benefit only seen with ER-positive DCIS ** Especially important in high-risk patients ** Probably not necessary after mastectomy ** Improves local control after breast-conserving therapy and prevents new tumours ** After 7 years, reduced ipsilateral breast cancer from 9% to 6% and reduced the risk of new contralateral breast cancer by 47% * Chemotherapy ** Not indicated, as the rate of metastatic disease is so low
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
DCIS
(section)
Add topic